Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract. 2000;17(3):261–7. https://doi.org/10.1093/fampra/17.3.261.
Article CAS PubMed Google Scholar
Morin L, Laroche ML, Texier G, et al. Prevalence of Potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862.e1-9. https://doi.org/10.1016/j.jamda.2016.06.011.
Tamura BK, Bell CL, Inaba M, et al. Outcomes of polypharmacy in nursing home residents. Clin Geriatr Med. 2012;28(2):217–36. https://doi.org/10.1016/j.cger.2012.01.005.
Lion S, Evrard P, Foulon V, et al. Drug–drug interactions in nursing home residents: analysis from the COME-ON trial. Age Ageing. 2023. https://doi.org/10.1093/ageing/afac278.
Storms H, Marquet K, Aertgeerts B, et al. Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: a systematic review. Eur J Gen Pract. 2017;23(1):69–77. https://doi.org/10.1080/13814788.2017.1288211.
Article PubMed PubMed Central Google Scholar
Anrys PMS, Strauven GC, Foulon V, et al. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19(10):884–90. https://doi.org/10.1016/j.jamda.2018.06.010.
Wallace E, McDowell R, Bennett K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol Ser A. 2016;72(2):271–7. https://doi.org/10.1093/gerona/glw140.
Ruggiero C, Dell’Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–58. https://doi.org/10.2165/11538240-000000000-00000.
Dalleur O, Spinewine A, Henrard S, et al. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–37. https://doi.org/10.1007/s40266-012-0016-1.
Guillot J, Justice AC, Gordon KS, et al. Contribution of potentially inappropriate medications to polypharmacy-associated risk of mortality in middle-aged patients: a national cohort study. J Gen Intern Med. 2024. https://doi.org/10.1007/s11606-024-08817-4.
Alshammari H, Al-Saeed E, Ahmed Z, et al. Reviewing potentially inappropriate medication in hospitalized patients over 65 using explicit criteria: a systematic literature review. Drug Healthc Patient Saf. 2021;13:183–210. https://doi.org/10.2147/DHPS.S303101.
Article PubMed PubMed Central Google Scholar
Hurley E, Dalton K, Byrne S, et al. Pharmacist-led deprescribing using STOPPFrail for frail older adults in nursing homes. J Am Med Dir Assoc. 2024;25(9): 105122. https://doi.org/10.1016/j.jamda.2024.105122.
Roh E, Cota E, Lee JP, et al. Polypharmacy in nursing homes. Clin Geriatr Med. 2022;38(4):653–66. https://doi.org/10.1016/j.cger.2022.05.007.
Statbel en het Federaal Planbureau. Bevolkingsvooruitzichten 2023–2070 [updated February 13, 2024; cited 2024 April 08]. https://www.plan.be/databases/data-35-nl-bevolkingsvooruitzichten_2022_2070. Accessed Jan 2023.
Gerkens S, Lefèvre M, Bouckaert N, et al. Performance of the Belgian health system: Report 2024. Health Services Research (HSR). Brussels. Belgian Health Care Knowledge Centre (KCE). 2024. KCE Reports 376C. https://doi.org/10.57598/R376C.
Anlay DZ, Paque K, Van Leeuwen E, et al. Tools and guidelines to assess the appropriateness of medication and aid deprescribing: an umbrella review. Br J Clin Pharmacol. 2024;90(1):12–106. https://doi.org/10.1111/bcp.15906.
Nyborg G, Straand J, Klovning A, et al. The Norwegian general practice—nursing home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care. 2015;33(2):134–41. https://doi.org/10.3109/02813432.2015.1041833.
Article PubMed PubMed Central Google Scholar
Khodyakov D, Ochoa A, Olivieri-Mui BL, et al. Screening tool of older person’s prescriptions/screening tools to alert doctors to right treatment medication criteria modified for US nursing home setting. J Am Geriatr Soc. 2017;65(3):586–91. https://doi.org/10.1111/jgs.14689.
Dijk MMT, Catharina AM, Pouw CK, Hertogh CMPM, et al. Medication appropriateness for older nursing home patients with a limited life expectancy: from STOPP/START version 2 to the ReNeWAL criteria. J Am Med Dir Assoc. 2024. https://doi.org/10.1016/j.jamda.2024.105143.
Lavan AH, Gallagher P, Parsons C, et al. STOPPFrail (Screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600–7. https://doi.org/10.1093/ageing/afx005.
Morin L, Laroche ML, Vetrano DL, et al. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. 2018;74(10):1333–42. https://doi.org/10.1007/s00228-018-2507-4.
Article PubMed PubMed Central Google Scholar
Curtin D, Gallagher P, O’Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing. 2021;50(2):465–71. https://doi.org/10.1093/ageing/afaa159.
Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician Medecin de Famille Canadien. 2018;64(1):17–27.
Tordoff JM, Ailabouni NJ, Browne DP, et al. Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand. Int J Clin Pharm. 2016;38(4):941–9. https://doi.org/10.1007/s11096-016-0318-1.
Article CAS PubMed Google Scholar
Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354–64.
PubMed PubMed Central Google Scholar
Curtin D, Jennings E, Daunt R, et al. Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria. J Am Geriatr Soc. 2020;68(4):762–9. https://doi.org/10.1111/jgs.16278.
Evrard P, Damiaens A, Patey AM, et al. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: a qualitative study of stakeholder groups. Explor Res Clin Soc Pharm. 2023;9: 100258.
PubMed PubMed Central Google Scholar
Farrell B, Conklin J, Dolovich L, et al. Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Res Soc Adm Pharm. 2019;15(6):780–9. https://doi.org/10.1016/j.sapharm.2018.08.010.
Langford AV, Warriach I, McEvoy AM, et al. What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Qual Saf. 2024. https://doi.org/10.1136/bmjqs-2024-017101.
Article PubMed PubMed Central Google Scholar
Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10): e1001885. https://doi.org/10.1371/journal.pmed.1001885.
Article PubMed PubMed Central Google Scholar
Maetens A, De Schreye R, Faes K, et al. Using linked administrative and disease-specific databases to study end-of-life care on a population level. BMC Palliat Care. 2016;15:1–10. https://doi.org/10.1186/s12904-016-0159-7.
Norwegian Institute of Public Health. ATC/DDD Index. https://atcddd.fhi.no/atc_ddd_index/. Accessed 6 Aug 2024.
Paque K, De Schreye R, Elseviers M, et al. Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases. Br J Clin Pharmacol. 2019;85(4):827–37. https://doi.org/10.1111/bcp.13874.
Article PubMed PubMed Central Google Scholar
Deprescribing guidelines and algorithms. [cited 2022/06/12].
Comments (0)